The associations with tau PET that are seen for CSF p-tau and t-tau in this, and many other studies [4, 5], seem to be driven by individuals early in the AD continuum, and as the disease progresses, the variability becomes greater [4]. The gene discussed is MAPT; the disease is Alzheimer disease.